Monitoring of Gefitinib Sensitivity with Radioiodinated PHY Based on EGFR Expression-Reference-Cited by-同舟云学术

Monitoring of Gefitinib Sensitivity with Radioiodinated PHY Based on EGFR Expression

Published:2014 Issue:3 Volume:37 Page:355-360
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Yoshimoto Mitsuyoshi¹²,Hirata Masahiko³,Kanai Yasukazu⁴,Naka Sadahiro⁵,Nishii Ryuichi⁶,Kagawa Shinya⁷,Kawai Keiichi²,Ohmomo Yoshiro³

Affiliation:

1. Division of Functional Imaging, National Cancer Center Hospital East

2. Faculty of Health Sciences, Kanazawa University

3. Osaka University of Pharmaceutical Sciences

4. Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine

5. Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine

6. Department of Radiology, Faculty of Medicine, University of Miyazaki

7. Research Institute, Shiga Medical Center

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/37/3/37_b13-00559/_pdf

Reference25 articles.

1. 1) Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183–232 (1995).

2. 2) Laskin JJ, Sandler AB. Epidermal growth factor receptor: a promising target in solid tumours. Cancer Treat. Rev., 30, 1–17 (2004).

3. 3) Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol., 2, 127–137 (2001).

4. 4) Marshall J. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer, 107, 1207–1218 (2006).

5. 5) Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J. Clin. Oncol., 21, 2237–2246 (2003).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examination of Driver Mutation-Specific MicroRNA Expression in Human Lung Adenocarcinoma Cell Lines;The Kitakanto Medical Journal;2024-02-01

2. Multiplexed CRISPR-Based Nucleic Acid Detection Using a Single Cas Protein;Analytical Chemistry;2023-10-26

3. Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer;Nanomaterials;2022-02-28

4. Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging;Bioorganic & Medicinal Chemistry;2019-01

5. Synthesis and evaluation of radioiodinated 1-{2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}piperidin-4-amine derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging;Bioorganic & Medicinal Chemistry;2017-10